...
首页> 外文期刊>Artificial Organs >y Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis
【24h】

y Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis

机译:Y通过直接血液灌注与血液透析患者联六烷基固定的纤维素珠的直接痔疮吸附蛋白质尿毒毒性毒素

获取原文
获取原文并翻译 | 示例

摘要

An accumulation of protein-bound uremic toxins (PBUTs) is one of major reasons for development of uremia-related complications. We examined the PBUT removal ability of a hexadecyl-immobilized cellulose bead (HICB)-containing column for patients undergoing hemodialysis. Adsorption of indoxyl sulfate (IS), a representative PBUT, to HICBs was examined in vitro. The HICB column was used in patients undergoing hemodialysis for direct hemoperfusion with a regular hemodialyzer. The serum IS, indole acetic acid (IAA), phenyl sulfate (PhS), and p-cresyl sulfate (PCS) levels were measured before and after passing the column. HICBs adsorbed protein-free (free) IS in a dose- and time-dependent manner in vitro (55.4 +/- 1.4% adsorption of 1 millimolar, 251 mu g/mL, IS for 1 h). In clinical studies, passing the HICB-containing column decreased the serum level of free IS, IAA, PhS, and PCS levels significantly (by 34.4 +/- 30.0%, 34.8 +/- 25.4%, 28.4 +/- 18.0%, and 34.9 +/- 22.1%, respectively), but not protein-bound toxins in maintenance hemodialysis patients. HICBs absorbed some amount of free PBUTs, but the clinical trial to use HICB column did not show effect to reduce serum PBUTs level in hemodialysis patients. Adsorption treatment by means of direct hemoperfusion with regular hemodialysis may become an attractive blood purification treatment to increase PBUT removal when more effective materials to adsorb PBUTs selectively will be developed.
机译:蛋白质结合的尿毒毒素(PBUT)的积累是开发尿毒症相关并发症的主要原因之一。我们检查了血液透析患者的十六烷基固定化纤维素珠(HICB)塔柱的PBUT去除能力。在体外检查吲哚基硫酸盐(IS)对HICBS的吸附。 HICB柱用于接受血液透析的患者用常规血液透析仪直接血液渗透。在通过塔之前和之后测量血清,吲哚乙酸(IAA),苯硫酸盐(pH)和p-烯丙酯(PCS)水平。 HICBS吸附的蛋白质(自由)在体外以剂量和时间依赖性方式(55.4 +/- 1.4%吸附1毫米,251μg/ ml为1小时)。在临床研究中,通过含HICB的塔的血清自由血清水平,IAA,PHS和PCS水平显着显着(34.4 +/- 30.0%,34.8 +/- 25.4%,28.4 +/- 18.0%,和34.9 +/- 22.1%,但在维持血液透析患者中​​没有蛋白质结合毒素。 HICBS吸收了一定量的免费PBUT,但使用HICB柱的临床试验未显示出血液透析患者中​​血清PBUT水平的效果。通过直接血液灌注用常规血液透析的吸附处理可能成为一种有吸引力的血液净化处理,以增加当更有效的材料选择性地选择性的吸附性血液中的PBUT去除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号